与临床试验相关的碳排放:范围审查
Frank You1, Taylor Coffey1, Daniel Powell2
1Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, UK.
Journal of clinical epidemiology
|February 24, 2025
概括
临床试验产生大量的碳排放,其中旅行,设施和样品生命周期是主要的贡献者. 需要进一步的研究来制定有效的策略,以减少绿色临床试验对环境的影响.
科学领域:
- 环境科学 环境科学
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- 临床试验对于医学进步至关重要,但对环境产生重大影响,特别是碳排放.
- 了解和量化这些排放对于开发可持续的研究实践至关重要.
研究的目的:
- 审查和综合现有关于临床试验碳排放的证据.
- 确定关键的碳热点,并为设计更绿色的临床试验提供信息.
主要方法:
- 根据乔安娜·布里格斯研究所和PRISMA-Scoping的指导方针进行了全面的范围审查.
- 从2007年到2024年,对MEDLINE (奥维德) 和引用分析 (雪球) 进行了系统的搜索.
- 包括所有关于临床试验碳排放的研究文献.
主要成果:
- 包括22篇文章,其中77%是在2020-2024年间发表的.
- 59%是初级研究研究,主要报告碳审计.
- 确定的主要碳热点包括与试验相关的旅行,设施和样品生命周期.
结论:
- 文献主要侧重于量化碳审计,使用各种方法和输出.
- 尽管有方法上的差异,但已经确定了常见的碳密集型试验过程.
- 减轻试验特定碳排放的策略需要进一步的研究和开发.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Hazard Ratio
96
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
96
COPD: Pathogenesis and Clinical Features
244
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


